Literature DB >> 19202426

Comparison of clinical outcomes and wound dynamics of sclerotomy ports of 20, 25, and 23 gauge vitrectomy.

Manish Nagpal1, Sharang Wartikar, Kamal Nagpal.   

Abstract

PURPOSE: To compare the benefits, the risks and the dynamics of port closure in different gauge vitrectomy systems.
METHODS: Prospective, randomized, comparative study of 90 eyes undergoing 20, 23 and 25 gauge (G) vitrectomy for uncomplicated vitreous hemorrhage due to proliferative diabetic retinopathy, vasculitis, trauma, venous occlusions and others. An endoscope was used in five cases of each group to visualize the inside of sclerotomy ports.
RESULTS: Vision improved from 0.048 (3/60) to 0.206 (6/24) (p = 0.0021), from 0.069 (4/60) to 0.389 (6/18) (p < 0.0001) and from 0.055 (3/60) to 0.286 (6/24) (p = 0.0010) with 20, 23, and 25-G systems, respectively. Re-bleeds occurred in 4, 1 and 4 eyes of 20, 23 and 25-G systems respectively and post-operative retinal detachment was seen in 2 cases of 20-G system. There were no cases of post-operative hypotony or endophthalmitis seen. With 23 and 25 gauge systems, significant amount of vitreous was seen blocking the inner lip of the sclerotomy ports.
CONCLUSION: The small gauge systems are safe and equally effective than the 20-G system for non-complicated vitreous hemorrhage cases with faster recovery and more comfort for the patient. Increased vitreous clogging with small gauge systems does not extrapolate to an increased risk of complications.

Entities:  

Mesh:

Year:  2009        PMID: 19202426     DOI: 10.1097/IAE.0b013e3181934908

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  29 in total

1.  Comparative study of 23-gauge vitrectomy versus 20-gauge vitrectomy for the treatment of rhegmatogenous retinal detachment.

Authors:  Magali Albrieux; Frédéric Rouberol; Diane Bernheim; Jean-Paul Romanet; Christophe Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-16       Impact factor: 3.117

2.  Asymptotic medicine.

Authors:  Karmen Loncarek
Journal:  Croat Med J       Date:  2009-02       Impact factor: 1.351

3.  25-Gauge pars plana vitrectomy for ciliary block (malignant) glaucoma.

Authors:  Li Meng; Wenbin Wei; Yanlong Li; Xiaoying Hui; Xiaodong Han; Xiaobo Shi
Journal:  Int Ophthalmol       Date:  2014-07-26       Impact factor: 2.031

4.  Iatrogenic retinal breaks and postoperative retinal detachments in microincision vitrectomy surgery compared with conventional 20-gauge vitrectomy: a meta-analysis.

Authors:  G H Chen; R Tzekov; F Z Jiang; S H Mao; Y H Tong; W S Li
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

Review 5.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

6.  25G compared with 20G vitrectomy under Resight non-contact wide-angle lenses for Terson syndrome.

Authors:  Xinbang Mao; Zhipeng You
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

7.  Conjunctival pigmentation after 23-gauge microincisional vitrectomy surgery.

Authors:  D H Park; J P Shin; S Y Kim
Journal:  Eye (Lond)       Date:  2011-08-19       Impact factor: 3.775

8.  Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.

Authors:  Morteza Entezari; Alireza Ramezani; Hamid Ahmadieh; Pejman Bakhtiari; Mehdi Yaseri; Kian Soltani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-25       Impact factor: 3.117

9.  Combined 20-gauge and 23-gauge pars plana vitrectomy for the management of posteriorly dislocated lens: a case series.

Authors:  Pipat Kongsap
Journal:  Clin Ophthalmol       Date:  2010-07-21

10.  Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion.

Authors:  Okan Toygar; Cindy W Mi; Daniel M Miller; Christopher D Riemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.